中国P站

Abstract

This collection of research highlights the evolving challenges in clinical mycology, marked by the rise of invasive fungal infec
tions and resistance. It underscores the importance of rapid diagnostics, molecular techniques, and biomarkers for improved patient
outcomes. Specific focus is given to Candida, Aspergillus, Cryptococcus, and Mucor species, with advancements in diagnosis and
treatment discussed. Antifungal resistance, particularly in Candida, is a growing concern, driving the need for new therapeutic strate
gies anddrugdevelopment. Theroleofbiomarkersandwhole-genomesequencingindiagnosticsisemphasized, asisthemanagement
of fungal infections in immunocompromised populations.